Personensuche
Personensuche
Es wurde 1 Person gefunden.
Funktionen
-
Oberarzt/-ärztin, Klinik für Neurologie
Aktuelle Veranstaltungen
Keine aktuellen Veranstaltungen.
Vergangene Veranstaltungen (max. 10)
-
2024 WS
-
2024 SS
-
2023 WS
-
2023 SS
-
2022 WS
Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.
-
Cancer-related cognitive impairment in patients with non-central nervous system malignancies : An overview for oncology providers from the MASCC Neurological Complications Study GroupIn: Supportive Care in Cancer Jg. 29 (2021) Nr. 6, S. 2821 - 2840Online Volltext: dx.doi.org/
-
Prospective evaluation of health care provider and patient assessments in chemotherapy-induced peripheral neurotoxicityIn: Neurology Jg. 97 (2021) Nr. 7, S. E660 - E672Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Periphere und zentrale Neurotoxizität nach TumortherapieIn: Pädiatrische Praxis Jg. 94 (2020) Nr. 1, S. 69 - 84
-
Periphere und zentrale Neurotoxizität nach TumortherapieIn: Tägliche Praxis Jg. 63 (2020) Nr. 3, S. 475 - 490
-
Patients' and physicians' interpretation of chemotherapy-induced peripheral neurotoxicityIn: Journal of the Peripheral Nervous System Jg. 24 (2019) Nr. 1, S. 111 - 119Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Periphere und zentrale Neurotoxizität nach TumortherapieIn: Internistische Praxis Jg. 61 (2019) Nr. 2, S. 313 - 328
-
Response assessment of meningioma : 1D, 2D, and volumetric criteria for treatment response and tumor progressionIn: Neuro-Oncology Jg. 21 (2019) Nr. 2, S. 234 - 241Online Volltext: dx.doi.org/ (Open Access)
-
Prophylaxe und Therapie der chemotherapieinduzierten PolyneuropathieIn: Best Practice Onkologie Jg. 13 (2018) Nr. 4, S. 214 - 225Online Volltext: dx.doi.org/
-
Kinetics of tumor size and peritumoral brain edema before, during, and after systemic therapy in recurrent WHO grade II or III meningiomaIn: Neuro-Oncology Jg. 18 (2016) Nr. 3, S. 401 - 407Online Volltext: dx.doi.org/
-
Long-term analysis of the NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with PCV or temozolomideIn: Neuro-Oncology Jg. 18 (2016) Nr. 11, S. 1529 - 1537Online Volltext: dx.doi.org/
-
Periphere Neurotoxizität : Präventive DosismodifikationIn: Der Onkologe Jg. 21 (2015) Nr. 4, S. 311 - 317Online Volltext: dx.doi.org/
-
Central nervous system lymphoma in a patient with mycosis fungoidesIn: Neuro-Oncology Jg. 16 (2014) Nr. Suppl 2, S. ii61Online Volltext: dx.doi.org/
-
Correspondence between neurophysiological and clinical measurements of chemotherapy-induced peripheral neuropathy: : Secondary analysis of data from the CI-PeriNomS studyIn: Journal of the Peripheral Nervous System Jg. 19 (2014) Nr. 2, S. 127 - 135Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Management options for established chemotherapy-induced peripheral neuropathyIn: Supportive Care in Cancer Jg. 22 (2014) Nr. 8, S. 2281 - 2295Online Volltext: dx.doi.org/
-
Neuromuscular complications after hematopoietic stem cell transplantationIn: Supportive Care in Cancer Jg. 22 (2014) Nr. 9, S. 2337 - 2341Online Volltext: dx.doi.org/
-
Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity : two sides of the same coinIn: Annals of Oncology Jg. 25 (2014) Nr. 1, S. 257 - 264Online Volltext: dx.doi.org/
-
Treatment of multiple myeloma: Thalidomide-, bortezomib-, and lenalidomide-induced peripheral neuropathyIn: Oncology Research and Treatment Jg. 37 (2014) Nr. 9, S. 506 - 513Online Volltext: dx.doi.org/
-
Prognostic or predictive value of MGMT promoter methylation in gliomas depends on IDH1 mutationIn: Neurology Jg. 81 (2013) Nr. 17, S. 1515 - 1522Online Volltext: dx.doi.org/
-
Rasch-built Overall Disability Scale for patients with chemotherapy-induced peripheral neuropathy (CIPN-R-ODS)In: European Journal of Cancer (EJC) Jg. 49 (2013) Nr. 13, S. 2910 - 2918Online Volltext: dx.doi.org/
-
The chemotherapy-induced peripheral neuropathy outcome measures standardization study : From consensus to the first validity and reliability findingsIn: Annals of Oncology Jg. 24 (2013) Nr. 2, S. 454 - 462Online Volltext: dx.doi.org/
-
Visual field defect related to temozolomideIn: Neuro-Oncology Jg. 15 (2013) Nr. Suppl. 3, S. 116Online Volltext: dx.doi.org/
-
New-Onset Parkinson Syndrome After Liver TransplantationIn: Transplantation Jg. 94 (2012) Nr. 8, S. e56 - e57Online Volltext: dx.doi.org/
-
Management der Polyneuropathie beim Multiplen Myelom unter der Therapie mit Bortezomib : Empfehlungen aus klinischen ErfahrungenIn: TumorDiagnostik & Therapie Jg. 32 (2011) Nr. 3, S. 153 - 158Online Volltext: dx.doi.org/
-
Treatable Bortezomib-related peripheral neuropathy in multiple myelomaIn: Journal of the Peripheral Nervous System Jg. 16 (2011) Nr. Suppl. 3, S. 68
-
Electrically evoked nociceptive potentials for early detection of diabetic small-fiber neuropathyIn: European Journal of Neurology Jg. 17 (2010) Nr. 6, S. 834 - 841Online Volltext: dx.doi.org/
-
Neurologic complications in adult living donor liver transplant patients : An underestimated factor?In: Journal of Neurology Jg. 257 (2010) Nr. 2, S. 253 - 258Online Volltext: dx.doi.org/ (Open Access)
-
Lack of neuroprotection by an ACTH (4-9) analogue : A randomized trial in patients treated with vincristine for Hodgkin's or non-Hodgkin's lymphomaIn: Journal of Cancer Research and Clinical Oncology Jg. 130 (2004) Nr. 3, S. 153 - 160Online Volltext: dx.doi.org/
-
Predominantly motor polyneuropathy following brentuximab vedotin
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 28. September - 2. Oktober 2018, Wien,In: Oncology Research and Treatment Jg. 41 (2018) Nr. Suppl. 4, S. 319Online Volltext: dx.doi.org/ (Open Access) -
Physician-assessed and petient-reported outcome measuresin chemotherapy-induced sensory peripheral neurotoxicity : two sides of the same coin
Meeting of the Peripheral Nerve Society, June 29–July 3, 2013, Saint–Malo, France,In: Journal of the Peripheral Nervous System Jg. 18 (2013) Nr. S2, S. 3 - 4Online Volltext: dx.doi.org/ -
Provider perceptions of clinical neuropathy examination usefulness
Meeting of the Peripheral Nerve Society, June 29–July 3, 2013, Saint–Malo, France,In: Journal of the Peripheral Nervous System Jg. 18 (2013) Nr. 2, S. 42 - 43Online Volltext: dx.doi.org/ -
An investigator-initiated monocentric phase I dose escalation trial of temsirolimus and irinotecan (TEMIR) in patients with relapsing glioblastoma multiforme (reGBM)
48th Annual Meeting of the American Society of Clinical Oncology (ASCO), June 1-5, 2012, Chicago, Ill., USA,In: Journal of Clinical Oncology (JCO) Jg. 30 (2012) Nr. 15, Suppl., 2086Online Volltext: dx.doi.org/